K
Kenichi Kaida
Researcher at National Defense Medical College
Publications - 86
Citations - 2414
Kenichi Kaida is an academic researcher from National Defense Medical College. The author has contributed to research in topics: Guillain-Barre syndrome & Chronic inflammatory demyelinating polyneuropathy. The author has an hindex of 23, co-authored 82 publications receiving 2042 citations. Previous affiliations of Kenichi Kaida include Saitama Medical University.
Papers
More filters
Journal ArticleDOI
Overlapping demyelinating syndromes and anti–N-methyl-D-aspartate receptor encephalitis.
Maarten J. Titulaer,Maarten J. Titulaer,Romana Höftberger,Romana Höftberger,Takahiro Iizuka,Frank Leypoldt,Frank Leypoldt,Lindsey McCracken,Tania Cellucci,Leslie Benson,Leslie Benson,Huidy Shu,Takashi Irioka,Makito Hirano,Gagandeep Singh,Alvaro Cobo Calvo,Kenichi Kaida,Pamela S. Morales,Paul W. Wirtz,Tomotaka Yamamoto,Markus Reindl,Myrna R. Rosenfeld,Francesc Graus,Albert Saiz,Josep Dalmau,Josep Dalmau,Josep Dalmau +26 more
TL;DR: In this paper, the authors report the clinical, radiological, and immunological association of demyelinating disorders with anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis.
Journal ArticleDOI
Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (PATH): a randomised, double-blind, placebo-controlled, phase 3 trial
Ivo N. van Schaik,Vera Bril,Nan van Geloven,Hans-Peter Hartung,Richard A. Lewis,Gen Sobue,John-Philip Lawo,Michaela Praus,Orell Mielke,Billie L. Durn,David R. Cornblath,Ingemar S. J. Merkies,A. Sabet,K. George,Leslie Roberts,R. Carne,Stefan Blum,Robert D. Henderson,P. Van Damme,J. Demeestere,S. Larue,C. D'Amour,Vera Bril,Ari Breiner,P. Kunc,Martin Vališ,J. Sussova,T. Kalous,R. Talab,M. Bednar,Toomas Toomsoo,Inna Rubanovits,Katrin Gross-Paju,U. Sorro,M. Saarela,Mari Auranen,Jean Pouget,Shahram Attarian,G. Le Masson,Anne-Cécile Wielanek-Bachelet,Claude Desnuelle,Emilien Delmont,Pierre Clavelou,D. Aufauvre,Jens Ejbye Schmidt,J. Zschuentssch,Claudia Sommer,D. Kramer,Olaf Hoffmann,C. Goerlitz,J. Haas,M. Chatzopoulos,R. Yoon,R. Gold,P. Berlit,A. Jaspert-Grehl,D. Liebetanz,A. Kutschenko,Martin Stangel,C. Trebst,P. Baum,Florian Then Bergh,Juliane Klehmet,Andreas Meisel,Fabian Klostermann,J. Oechtering,Helmar C. Lehmann,Michael Schroeter,Tim Hagenacker,D. Mueller,Anne D. Sperfeld,F. Bethke,Vivian E. Drory,A. Algom,David Yarnitsky,B. Murinson,A. Di Muzio,F. Ciccocioppo,Sandro Sorbi,Sabrina Matà,Angelo Schenone,Marina Grandis,Giuseppe Lauria,Daniele Cazzato,Giovanni Antonini,Stefania Morino,Dario Cocito,M. Zibetti,Takanori Yokota,Takuya Ohkubo,Takashi Kanda,M. Kawai,Kenichi Kaida,H. Onoue,Satoshi Kuwabara,Masahiro Mori,Masahiro Iijima,K. Ohyama,Masayuki Baba,M. Tomiyama,K. Nishiyama,Tsugio Akutsu,Kazumasa Yokoyama,K. Kanai,I. N. van Schaik,Filip Eftimov,Nicolette C. Notermans,Nora A. Visser,C. G. Faber,Janneke G. J. Hoeijmakers,Konrad Rejdak,U. Chyrchel-Paszkiewicz,C. Casanovas Pons,M. Alberti Aguiló,Josep Gamez,Maria Salvado Figueras,C. Marquez Infante,S. Benitez Rivero,Michael P. Lunn,Jasper M. Morrow,David Gosal,T. Lavin,I. Melamed,Alessandro Testori,Senda Ajroud-Driss,Daniela M. Menichella,Ericka Simpson,E. Chi-Ho Lai,Mazen M. Dimachkie,Richard J. Barohn,Said R. Beydoun,H. Johl,Dale J. Lange,Alexander Shtilbans,S. Muley,Shafeeq Ladha,Miriam Freimer,John T. Kissel,Norman Latov,Russell L. Chin,Eroboghene E. Ubogu,S. Mumfrey,T. Rao,P. MacDonald,Khema Sharma,Ginna Gonzalez,Jeffrey A. Allen,David Walk,Lisa D. Hobson-Webb,Karissa L. Gable +149 more
TL;DR: This study, which is to the authors' knowledge, the largest trial of CIDP to date and the first to study two administrations of immunoglobulins and two doses, showed that both doses of SCIg IgPro20 were efficacious and well tolerated, suggesting thatSCIg can be used as a maintenance treatment for C IDP.
Journal ArticleDOI
Ganglioside complexes as new target antigens in Guillain-Barré syndrome.
Kenichi Kaida,Daiji Morita,Mami Kanzaki,Keiko Kamakura,Kazuo Motoyoshi,Minako Hirakawa,Susumu Kusunoki +6 more
TL;DR: Antibodies specific for a complex of gangliosides GD1a and GD1b (GD1a/GD1b) were found in sera from eight of 100 patients with Guillain–Barré syndrome by the use of enzyme‐linked immunosorbent assay and thin‐layer chromatogram immunostaining.
Journal ArticleDOI
Anti-ganglioside complex antibodies in Miller Fisher syndrome
Kenichi Kaida,Mami Kanzaki,Daiji Morita,Keiko Kamakura,Kazuo Motoyoshi,Minako Hirakawa,Susumu Kusunoki +6 more
TL;DR: In patients with MFS not only G Q1b itself but also clustered epitopes of GSCs, including GQ1b, may be considered to be prime target antigens for serum antibodies, and a tendency to escape sensory disturbances is shown by anti-GQ1 b/GM1-positive MFS.
Journal ArticleDOI
Safety and efficacy of eculizumab in Guillain-Barré syndrome: a multicentre, double-blind, randomised phase 2 trial
Sonoko Misawa,Satoshi Kuwabara,Yasunori Sato,Nobuko Yamaguchi,Kengo Nagashima,Kanako Katayama,Yukari Sekiguchi,Yuta Iwai,Hiroshi Amino,Tomoki Suichi,Takanori Yokota,Yoichiro Nishida,Tadashi Kanouchi,Nobuo Kohara,Michi Kawamoto,Junko Ishii,Motoi Kuwahara,Hidekazu Suzuki,Koichi Hirata,Norito Kokubun,Ray Masuda,Juntaro Kaneko,Ichiro Yabe,Hidenao Sasaki,Kenichi Kaida,Hiroshi Takazaki,Norihiro Suzuki,Shigeaki Suzuki,Hiroyuki Nodera,Naoko Matsui,Shoji Tsuji,Haruki Koike,Ryo Yamasaki,Susumu Kusunoki,S Misawa,S Kuwabara,Y Sato,N Yamaguchi,K Nagashima,K Katayama,Y Sekiguchi,Y Iwai,H Amino,T Suichi,T Yokota,Y Nishida,T Kanouchi,N Kohara,M Kawamoto,J Ishii,M Kuwahara,H Suzuki,K Hirata,N Kokubun,R Masuda,J Kaneko,I Yabe,H Sasaki,K Kaida,H Takazaki,N Suzuki,S Suzuki,H Nodera,N Matsui,S Tsuji,H Koike,R Yamasaki,S Kusunoki,T Nagashima,T Shimizu,M Hirotani,M Kadoya,Jin Nakahara,J Shimizu,M Tanaka,G Sobue,Masahisa Katsuno,H Yamaguchi,H Ogata +78 more
TL;DR: The safety and efficacy of eculizumab, a humanised monoclonal antibody against the complement protein C5, in patients with severe Guillain-Barré syndrome is investigated and the primary outcome measure did not reach the predefined response rate.